Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Cancer & Clinical Oncology|February 1, 1989
Carrier mediated action of platinum complexes on estrogen receptor positive tumorsN Knebel, C D Schiller, M R Schneider, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1982
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compoundG Kranzfelder, R W Hartmann, E von Angerer, et al.
Journal of Medicinal Chemistry|September 1, 1982
1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting propertiesM R Schneider, E von Angerer, H Schönenberger, et al.
Journal of Medicinal Chemistry|September 18, 1992
6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activityT Polossek, R Ambros, S von Angerer, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 30, 1998
Asthma management: the challenge of equivalenceV W Steinijans, M Neuhäuser, T Hummel, et al.
Respiration; International Review of Thoracic Diseases|September 7, 2006
Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challengeC Louw, Z Williams, L Venter, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1981
The tumor-inhibiting effect of diethylstilbestrol-3,4-oxideM R Schneider, G Kranzfelder, E von Angerer, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1984
The tumor-inhibiting effect of isomeric dichloro(diphenylethylenediamine)platinum(II) complexesB Wappes, M Jennerwein, E von Angerer, et al.
Pageof 7